A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases

Chang, 2004, Ischemic heart disease mortality reduction in an arseniasis-endemic-endemic area in southwestern Taiwan after a switch in the tap-water supply system, J. Toxicol. Environ. Health, 7, 1353, 10.1080/15287390490471451 Chen, 1988, Arsenic and cancers, Lancet, 20, 414, 10.1016/S0140-6736(88)91207-X Chen, 1988, Atherogenicity and carcinogenicity of high-arsenic artesian well water: multiple risk factors and related malignant neoplasms of blackfoot disease, Arteriosclerosis, 18, 452, 10.1161/01.ATV.8.5.452 Chen, 1996, Dose response relationship between ischemic hear disease mortality and long-term arsenic exposure, Arterioscler., Thromb., Vasc. Biol., 16, 504, 10.1161/01.ATV.16.4.504 Chen, 1999, Emergent epidemics of arseniasis in Asia, 113 Chen, 2005, Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan, Toxicol. Appl. Pharmacol., 206, 198, 10.1016/j.taap.2004.10.023 Chiou, 1997, Dose–response relationship between prevalence of cerebrovascular disuse and ingested inorganic arsenic, Stroke, 28, 1717, 10.1161/01.STR.28.9.1717 Chiou, 2001, Arsenic exposure, null genotypes of glutathione S-transferase M1, T1 and P1, and risk of carotid atherosclerosis among residents in Lanyang Basin of Taiwan, 207 Engel, 1994, Arsenic in drinking water and mortality from vascular disease: an ecological analysis in 30 counties in the United States, Arch. Environ. Health, 49, 418, 10.1080/00039896.1994.9954996 Hertz-Picciotto, 2000, Does arsenic exposure increase the risk for circulatory disease?, Am. J. Epidemiol., 151, 174, 10.1093/oxfordjournals.aje.a010185 Hsueh, 1998, Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure, Atherosclerosis, 141, 249, 10.1016/S0021-9150(98)00178-6 Lagerkvist, 1988, Arsenic and Raynaud's phenomenon, Int. Arch. Occup. Environ. Health, 60, 361, 10.1007/BF00405671 Lewis, 1999, Drinking water arsenic in Utah: a cohort mortality study, Environ. Health Perspect., 107, 359, 10.1289/ehp.99107359 Lin, 1988, Arsenic, selenium and zinc inpatients with blackfoot disease, Biol. Trace Elem. Res., 15, 213, 10.1007/BF02990138 National Research Council, 1999 National Research Council, 2001 Navas-Acien, 2005, Arsenic and cardiovascular disease: a systemic review of the epidemiologic evidence, Am. J. Epidemiol., 162, 1027, 10.1093/aje/kwi330 Nordstrom, 2002, Worldwide occurrences of arsenic in ground water, Science, 296, 2143, 10.1126/science.1072375 Rosenberg, 1974, Systemic arterial disease and chronic arsenicism in infants, Arch. Pathol., 97, 360 Smith, 2000, Contamination of drinking-water by arsenic in Bangladesh: a public health emergency, Bull. World Health Org., 78, 1093 Smith, 2002, Arsenic epidemiology and drinking water standards, Science, 296, 2145, 10.1126/science.1072896 Tsai, 1999, Mortality for certain diseases in areas with high level of arsenic in drinking water, Arch. Environ. Health, 54, 186, 10.1080/00039899909602258 Tseng, 1977, Effects and dose–response relationships of skin cancer and black foot disease with arsenic, Environ. Health Perspect., 19, 109, 10.1289/ehp.7719109 Tseng, 1989, Blackfoot disease in Taiwan: a 30-year follow-up study, Angiology, 40, 547, 10.1177/000331978904000606 Tseng, 1995, Abnormal peripheral microcirculation in seemingly normal subjects living in blackfoot-disease-hyperendemic villages in Taiwan, Int. J. Microcirc. Clin. Exp., 15, 21, 10.1159/000178945 Tseng, 1996, Dose–response relationship between peripheral vascular disease and ingested arsenic among residents in blackfoot disease endemic villages in Taiwan, Atherosclerosis, 120, 125, 10.1016/0021-9150(95)05693-9 Tseng, 2003, Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan, Toxicol. Lett., 127, 15, 10.1016/S0378-4274(02)00377-6 Wang, C.H., 2003. Cardiovascular effects of chronic arsenic poisoning. Doctoral Thesis. National Taiwan University, Taipei, Taiwan. Wang, 2001, Arterial tissue of arsenic, selenium and iron in blackfoot disease patients, Clin. Chem. Lab. Med., 39, 645, 10.1515/CCLM.2001.105 Wang, 2002, Biological gradient between long-term arsenic exposure and carotid atherosclerosis, Circulation, 105, 1804, 10.1161/01.CIR.0000015862.64816.B2 Wang, Y.H., Wu, M.M., Hong, C.T., Lien, L.M., Hsieh, Y.C., Tseng, H.P., Chang, S.F., Su, C.L., Chiou, H.Y., Chen, C.J., in press. Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P on the risk of carotid atherosclerosis in Taiwan. Atherosclerosis. World Health Organization, 1981, 43 Wu, 1989, Dose–response relationship between arsenic concentration in well water and mortality from cancers and vascular disease, Am. J. Epidemiol., 130, 1123, 10.1093/oxfordjournals.aje.a115439 Wu, 2001, Association of arsenic exposure with increased reactive oxidants and decreased antioxidant capacity in a human population of Northeastern Taiwan, Environ. Health Perspect., 109, 1011, 10.1289/ehp.011091011 Wu, 2003, Gene expression of inflammatory molecules in circulating lymphocytes form arsenic-exposed human subjects, Environ. Health Perspect., 111, 1429, 10.1289/ehp.6396 Yang, 2006, Dose arsenic exposure increase the risk of development of peripheral vascular diseases in humans?, J. Toxicol. Environ. Health, Part A, 69, 1797, 10.1080/15287390600630237 Yeh, 1963, A pathological study on the blackfoot disease in Taiwan, Reports Inst. Pathol. Natl. Taiwan Univ., 14, 25 Yu, 2002, Peripheral vascular disease resulting from chronic arsenic poisoning, J. Dermatol., 29, 123, 10.1111/j.1346-8138.2002.tb00234.x Zierold, 2004, Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water, Am. J. Public Health, 94, 1936, 10.2105/AJPH.94.11.1936